Featured News
UCLA Symposium on Clinical Metagenomic Technology
Due to tremendous advances in genomic sequencing, clinical metagenomics is poised to revolutionize diagnostics for infectious diseases. The purpose of this symposium was to bring together researchers developing and deploying clinical metagenomic NGS technology to share best practices and the latest technological advances. The symposium also discussed key challenges and paths forward for regulatory approval, and commercialization of clinical metagenomic NGS diagnostic technologies.
UCLA researchers develop test to detect pathogens separate from COVID-19
By Aparna Pillai | Daily Bruin
UCLA researchers are working on a single test that can detect pathogens beyond COVID-19.
UCLA SwabSeq funded by BARDA
By UCLA | Computational Medicine Department
UCLA SwabSeq funded by BARDA to develop “agnostic” virus test.